GC and ovarian cancer: VDBP has not previously been reported as an ovarian cancer marker, although using a peptide profiling approach, endogenous proteolytic fragments of VDBP were identified in ascites fluid from ovarian cancer patients, but not from control patients with liver cirrhosis 33.